Search

everythinglearnresearchcommunity

for

Search:↓

During COVID-19, Iraqi women saw more hair loss and skin issues like acne due to stress, masks, and hygiene habits.

The COVID-19 pandemic increased some stress-related skin diseases but didn't affect others.

The COVID-19 pandemic affected hair restoration practices in 2022.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

A woman experienced sudden hair graying and loss after a COVID-19 vaccine, which improved with treatment.

A person with a new mutation in the SCN1A gene developed brain inflammation after COVID-19.

Interest in COVID-19 hair loss increased during COVID-19 surges, especially in higher-income countries.

During COVID-19, Iraqi women experienced more hair loss and skin issues like acne, likely due to stress and mask-wearing.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.

Some COVID-19 patients in Saudi Arabia had skin symptoms, with rashes being the most common.

Topical Minoxidil is effective for hair loss after COVID-19.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

A team of different healthcare experts is good for treating long-term COVID-19 issues.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

The COVID-19 pandemic caused most hair transplant surgeons in India to stop working, and many planned to change their safety measures afterwards.

No significant link between male pattern baldness and severe Covid-19, but some shared biological pathways exist.

Women are more likely to have long-term post-COVID symptoms than men.

A skin rash after the AstraZeneca COVID-19 vaccine was treated successfully with medication.

Some drugs may help treat both COVID-19 and radiation injury.

Non-hospitalized COVID-19 patients often have lingering symptoms for at least 30 days.

Most hospitalized COVID-19 survivors in the study experienced long-term symptoms, affecting their daily life and mental functions.

Long COVID causes lasting symptoms and needs ongoing care.

Blood type affects COVID-19 infection rates differently in Europe and Africa.

COVID-toes show a unique immune response over time, different from vaccine-related chilblains.

Long-COVID can cause lasting symptoms, but treatment with Erbisol drugs may help.

Older age and related diseases increase COVID-19 risk, but anti-aging treatments might help.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Minoxidil can improve hair growth in some patients with woolly hair due to LIPH variants, with varying responses and mild side effects.